Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients

Gruson, Damien; Ferracin, Benjamin; Ahn, Sylvie A.; Rousseau, Michel

doi:10.1016/j.ijcard.2015.04.074

Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients

Gruson, Damien

;

Ferracin, Benjamin

;

Ahn, Sylvie A.

;

Rousseau, Michel

(2015) International Journal of Cardiology — Vol. 189, n° 1, p. 185-187 (2015)

Files

pdfdocument.pdf

Restricted Access
Adobe PDF
235.88 KB

Request a copy

Details

Authors

Gruson, DamienUCLouvain
Author
Ferracin, BenjaminUCLouvain
Author
Ahn, Sylvie A.
Author
Rousseau, MichelUCLouvain
Author

Affiliations

UCLouvainSSS/IREC/CARD - Pôle de recherche cardiovasculaire
UCLouvainSSS/IREC/EDIN - Pôle d'endocrinologie, diabète et nutrition
UCLouvain(SLuc) Service de cardiologie
UCLouvain(SLuc) Service de biochimie médicale

Citations

APA
Chicago
FWB

Gruson, D., Ferracin, B., Ahn, S. A., & Rousseau, M. (2015). Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients. International Journal of Cardiology, 189(1), 185-187. https://doi.org/10.1016/j.ijcard.2015.04.074 (Original work published 2015)